
Danu Pharma Llp
Pharmaceutical trading and formulation with global reach, established in 2020.
Pharmaceutical trading and formulation with global reach, established in 2020.
Danu Pharma Llp (DPL) is 4 Year, 9 Months old Limited Liability Partnership 12 August 2020. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active. It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
AAT-3175
12 Aug 2020
-
Roc-Mumbai
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bhupendra Danu ![]() | Designated Partner | 12-Aug-2020 | Current |
Rajendra Bora ![]() | Designated Partner | 12-Aug-2020 | Current |
Mahendra Bhosle ![]() | Designated Partner | 12-Aug-2020 | Current |
Enhance accessibility to Danu Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Danu Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Bhupendra Danu is a mutual person
Bhupendra Danu and Rajendra Bora are mutual person
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Danu Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Danu Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Danu Pharma Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bhupendra Singh Madhav Singh Danu was appointed as a Designated Partner was appointed as a Designated Partner on 12 Aug 2020 & has been associated with this company since 4 years 9 months .
Rajendra Kedar Singh Bora was appointed as a Designated Partner was appointed as a Designated Partner on 12 Aug 2020 & has been associated with this company since 4 years 9 months .
Mahendra Anant Bhosle was appointed as a Designated Partner was appointed as a Designated Partner on 12 Aug 2020 & has been associated with this company since 4 years 9 months .
Danu Pharma Llp was registered on 12 Aug 2020 with RoC-Mumbai & aged 4 years 9 months as per MCA records.
Danu Pharma Llp was incorporated on 12 Aug 2020.
The Obligation of Contribution of Danu Pharma Llp is ₹ 0.10 M.
Currently 3 partners are associated with Danu Pharma Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Danu Pharma Llp is Flat No 301 Swapanpurti 11 Jivlapada Thakur Villege Building B1 Kandivali East Na City, Mumbai, Maharashtra, India, 400101.
The Limited Liability Partnership Identification Number (LLPIN) of Danu Pharma Llp is AAT-3175.
Search company & director profiles for free and gain access to critical business data.